Skip to main content

Table 2 Summary of biochemical analyses in non-lethal Raine syndrome individuals

From: Variability of systemic and oro-dental phenotype in two families with non-lethal Raine syndrome with FAM20C mutations

Patient (Family.)

Family 2

Family 2

Pedigree number

IV-4

IV-5

IV-6

VI-1

VI-2

Gender

Male

Male

Female

Male

Male

Age (years)

16

24

15

13

18

7

9

11

6

8

10

Serum calcium (8.8 – 11 mg/dL)

9.1 (N)

9.3 (N)

9.6 (N)

10,2 (N)

9.0 (N)

8.9 (N)

9.2 (N)

9.2 (N)

8.7 (N)

9.6 (N)

9.0 (N)

Serum phosphate (age dependent)

4.9 (N)

2.3 (↓)

4.6 (N)

4.7 (N)

2.6 (↓)

4.7 (N)

3.8 (N)

3.3 (↓)

4.4 (N)

3.4 (↓)

3.3 (↓)

Serum alkaline phosphatase (age dependent)

1462 (↑)

90 (N)

432 (↑)

380 (↑)

89 (N)

406 (↑)

457 (↑)

--

365 (↑)

385 (↑)

--

PTH (12 – 65 pg/mL)

NA

NA

NA

NA

NA

95.7 (↑)

55 (N)

71.4 (↑)

103 (↑)

35.8 (N)

52 (N)

Urinary calcium (<4 mg/kg/day)

--

--

79.8

112,2

--

0.5 (N)

2.1 (N)

0.71 (N)

0.8 (N)

1.3 (N)

0.65 (N)

Urinary phosphate (<15 mg/kg/day)

--

--

122.3

143,6--

--

11.31 (N)

23.2 (↑)

15.7 (↑)

10.5 (N)

30.5 (↑)

11.0 (N)

TPR (>85%)

--

--

--

--

--

89 (N)

88 (N)

79 (↓)

90.5 (N)

86 (N)

84 (↓)

  1. N = normal; NA = not assessed. Age-dependent metabolites: Serum phosphate: < 6 months: 4,8 – 7,4 mg/dL; 6 m – 5 years: 4,5 - 6,2 mg/dL;6 y – 1y before growth spurt: 3,6 – 5,8 mg/dL; after growth spurt: 2,5 – 4,5 mg/dL Alkaline phosphatase: 7 months −1 years: < 462 U/L; 1 – 3 years: < 281 U/L; 4–6 years: < 269 U/L; 7–12 years:< 300 U/L; 13–20 years: men: < 390 U/L, women: < 187 U/L; adults: men: 40–129 U/L, women: 35–104 U/L. Convertion: pmol/L x 9.497 = pg/mL; mmol/L x 18 = mg/dL.